These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 8137304

  • 1. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT, Schneider B, Domann R, Kulesz-Martin M.
    Cancer Res; 1994 Apr 01; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [Abstract] [Full Text] [Related]

  • 2. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.
    Domann FE, Levy JP, Birrer MJ, Bowden GT.
    Cell Growth Differ; 1994 Jan 01; 5(1):9-16. PubMed ID: 8123597
    [Abstract] [Full Text] [Related]

  • 3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH.
    Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737
    [Abstract] [Full Text] [Related]

  • 4. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A.
    Oncogene; 2000 Aug 17; 19(35):4011-21. PubMed ID: 10962557
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH, Greenhalgh DA.
    Princess Takamatsu Symp; 1989 Aug 17; 20():281-8. PubMed ID: 2518687
    [Abstract] [Full Text] [Related]

  • 6. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D, Welty D, Glick A, Greenhalgh D, Hennings H, Yuspa SH.
    Cancer Res; 1992 Jun 01; 52(11):3145-56. PubMed ID: 1375535
    [Abstract] [Full Text] [Related]

  • 7. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
    Harris CC, Reddel R, Pfeifer A, Iman D, McMenamin M, Trump BF, Weston A.
    IARC Sci Publ; 1991 Jun 01; (105):294-304. PubMed ID: 1855868
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 9. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes.
    Finch S, Joseloff E, Bowden T.
    J Cancer Res Clin Oncol; 2002 Jan 01; 128(1):3-10. PubMed ID: 11862466
    [Abstract] [Full Text] [Related]

  • 10. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.
    Caulín C, Bauluz C, Gandarillas A, Cano A, Quintanilla M.
    Exp Cell Res; 1993 Jan 01; 204(1):11-21. PubMed ID: 7677983
    [Abstract] [Full Text] [Related]

  • 11. Functional loss of tumour suppressor genes in multistage chemical carcinogenesis.
    Balmain A, Kemp CJ, Burns PA, Stoler AB, Fowlis DJ, Akhurst RJ.
    Princess Takamatsu Symp; 1991 Jan 01; 22():97-108. PubMed ID: 1844254
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7.
    Zenklusen JC, Oshimura M, Barrett JC, Conti CJ.
    Oncogene; 1994 Oct 01; 9(10):2817-25. PubMed ID: 8084587
    [Abstract] [Full Text] [Related]

  • 13. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M, Mattern J.
    Anticancer Res; 1993 Oct 01; 13(6A):2021-5. PubMed ID: 8297109
    [Abstract] [Full Text] [Related]

  • 14. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
    Darwiche N, Scita G, Jones C, Rutberg S, Greenwald E, Tennenbaum T, Collins SJ, De Luca LM, Yuspa SH.
    Cancer Res; 1996 Nov 01; 56(21):4942-9. PubMed ID: 8895748
    [Abstract] [Full Text] [Related]

  • 15. Identification of differentially expressed genes in chemically induced skin tumors.
    Rutberg SE, Lee EJ, Hansen LH, Glick AB, Yuspa SH.
    Mol Carcinog; 1997 Sep 01; 20(1):88-98. PubMed ID: 9328439
    [Abstract] [Full Text] [Related]

  • 16. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss.
    Boukamp P, Peter W, Pascheberg U, Altmeier S, Fasching C, Stanbridge EJ, Fusenig NE.
    Oncogene; 1995 Sep 07; 11(5):961-9. PubMed ID: 7675455
    [Abstract] [Full Text] [Related]

  • 17. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE, Adams TL, Glick A, Bonovich MT, Vinson C, Yuspa SH.
    Cancer Res; 2000 Nov 15; 60(22):6332-8. PubMed ID: 11103794
    [Abstract] [Full Text] [Related]

  • 18. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC.
    Cancer Res; 2005 Feb 01; 65(3):861-7. PubMed ID: 15705884
    [Abstract] [Full Text] [Related]

  • 19. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells.
    Domann FE, Levy JP, Finch JS, Bowden GT.
    Mol Carcinog; 1994 Feb 01; 9(2):61-6. PubMed ID: 8142009
    [Abstract] [Full Text] [Related]

  • 20. Molecular carcinogenesis of squamous cell carcinomas of the skin.
    Kubo Y, Murao K, Matsumoto K, Arase S.
    J Med Invest; 2002 Aug 01; 49(3-4):111-7. PubMed ID: 12322999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.